# Reservoir Neuroscience

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/reservoir-neuroscience

- Industry: Biotechnology
- Headquarters: Emeryville, US
- Website: www.reservoirneuro.com
- Total disclosed funding: $2.1M
- Latest round: Seed (Nov 14, 2023)
- Investors on record: 3

## About

Based in California, US, and founded in 2019 by its CEO Aaron Friedman, and co-founder Vlad Senatorov, Reservoir Neuroscience operates as a biotechnology firm that develops novel therapeutics to treat brain disease. In November 2024, Reservoir Neuroscience raised USD 2 million in venture funding led by new investor KIZOO Technology Ventures, with participation from returning investors R42 and Healthspan Capital. 

Reservoir Neuroscience develops a drug that specifically targets vascular disease, offering a novel avenue for restoring and rejuvenating the aging brain. 

The company plans to use the venture funding to develop its novel class of drug compounds.

## Funding rounds

- Seed, Nov 14, 2023, $2.1M — KIZOO Technology Ventures, R42, Healthspan Capital

## Investors

- KIZOO Technology Ventures (https://capitalatlas.ai/funds/kizoo-technology-ventures) — Seed
- R42 (https://capitalatlas.ai/funds/r42) — Seed
- Healthspan Capital (https://capitalatlas.ai/funds/healthspan-capital) — Seed